aluminum tri-tert-butoxide

• 分子结构分类: 有机化合物 - 有机氧化合物 - 有机氧化物
• 英文名称: aluminum tri-tert-butoxide
• 英文别名: Tri-t-butoxyaluminium；tris[(2-methylpropan-2-yl)oxy]alumane
• 化学式: C₁₂H₂₇AlO₃
• 分子量: 246.326
• InChiKey: MDDPTCUZZASZIQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.05
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  69.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  aluminum tri-tert-butoxide 在 盐酸 、 草酸 作用下， 以 乙醇 为溶剂， 反应 57.0h， 生成 aluminum oxide
  参考文献：
  名称：

  Synthesis, characterization and insights into stable and well organized hexagonal mesoporous zinc-doped alumina as promising metathesis catalysts carrier

  摘要：

  ZnCl₂修饰的六角介孔氧化铝成功合成，形成Al–O–Zn–Cl物种，用于支持甲基三氧化重铼催化剂进行甲基油酸甲酯自交换反应。

  DOI：

  10.1039/c4dt03630a
• 作为产物：
  描述：

  叔丁醇 生成 aluminum tri-tert-butoxide
  参考文献：
  名称：

  DODONOV, V. A.;STEPOVIK, L. P.;SOFRONOVA, S. M.;ZINCHENKO, V. A., ZH. OBSHCH. XIMII, 60,(1990) N, S. 1125-1130

  摘要：

  DOI：

文献信息

• 12-hetero substituted 6,11-ethano-6,11-dihydrobenzo (b) quinolizinium
  申请人：Sterling Winthrop Inc.

  公开号：US05380729A1

  公开（公告）日：1995-01-10

  1-Hetero substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment or prevention of neurodegenerative disorders or neurotoxic injuries utilizing them.

  1-含有杂原子取代的6,11-乙烷-6,11-二氢苯并[b]喹啉盐，含有它们的制药组合物，以及利用它们治疗或预防神经退行性疾病或神经毒性损伤的方法。
• Meiosis regulating compounds
  申请人：——

  公开号：US20020183283A1

  公开（公告）日：2002-12-05

  Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.

  某些新型甾醇衍生物可以用于调节卵母细胞和雄性生殖细胞中的减数分裂。
• Imidazolyl derivatives as corticotropin releasing factor inhibitors
  申请人：——

  公开号：US20020183375A1

  公开（公告）日：2002-12-05

  The present invention relates to novel heterocyclic antagonists of Formula (I) and pharmaceutical compositions comprising said antagonists of the corticotropin releasing factor receptor (“CRF receptor”) 1 useful for the treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms and other conditions the treatment of which can be effected by the antagonism of the CRF-1 receptor.

  本发明涉及一种新型杂环拮抗剂，其化学式为(I)，以及包含所述拮抗剂的药物组合物，用于治疗抑郁症、焦虑症、情感障碍、进食障碍、创伤后应激障碍、头痛、药物成瘾、炎症性疾病、药物或酒精戒断症状和其他可以通过拮抗CRF-1受体来治疗的疾病。
• Substituted heterocyclylisoquinolinium salts and compositions and
  申请人：Sterling Winthrop Inc.

  公开号：US05604224A1

  公开（公告）日：1997-02-18

  Substitutued heterocyclylisoquinolinium salts, pharmaceutical compositions containing them and methods for the treatment or prevention of neurodegenerative disorders or neurotoxic injuries utilizing them.

  替代杂环异喹啉盐，含有它们的制药组合物以及利用它们治疗或预防神经退行性疾病或神经毒性损伤的方法。
• Complex catalyst, process for producing the complex catalyst, and process for producing alchohol derivative with the complex catalyst
  申请人：——

  公开号：US20040077487A1

  公开（公告）日：2004-04-22

  There are provided (asymmetric) complex catalysts comprising metal complexes and Lewis acids as components, the metal complex being of formula (1): 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are the same or different and are independently hydrogen, halogen, alkyl or the like; one of R 9 and R 10 is hydrogen and the other is alkyl of 1 to 4 carbon atoms or the like; Q is a single bond or alkylene of 1 to 4 carbon atoms; M is a metal ion; and A is a balancing counter ion or ligand; processes for the production of these complex catalysts; processes for the production of (optically active) alcohol derivatives, characterized in that cyclic ether compounds are reacted with phenol derivatives in the presence of these complex catalysts; and further processes for producing (optically active) nitrogen-containing heterocyclic compounds by reacting these alcohol derivatives with halogenated nitrogen-containing heterocyclic compounds in the presence of a base.

  提供了由金属配合物和路易斯酸组成的（不对称的）复杂催化剂，其中金属配合物的化学式为（1）：1其中R1、R2、R3、R4、R5、R6、R7和R8相同或不同，独立地是氢、卤素、烷基或类似物；R9和R10中的一个是氢，另一个是1至4个碳原子的烷基或类似物；Q是单键或1至4个碳原子的烷基；M是金属离子；A是平衡的反离子或配体；制备这些复杂催化剂的方法；制备（光学活性的）醇衍生物的方法，其特征在于在这些复杂催化剂的存在下，环氧化合物与酚衍生物反应；以及在碱的存在下，通过将这些醇衍生物与卤素化的含氮杂环化合物反应，制备（光学活性的）含氮杂环化合物的进一步方法。

表征谱图